Nel ASA Shares Tumble 9% in Sentiment-Driven Selloff as Market Awaits Commercial Breakthrough

Nel ASA shares fell 9% on sentiment despite strong year-to-date gains. Q1 revenue dropped 5%, new orders collapsed 73%. Cash reserves and new alkaline platform offer hope. Half-year report due July 15.

Nel ASA’s stock took a sharp hit on Monday, sliding nearly 9% to €0.319 in Tradegate trading without any fresh corporate news to explain the move. By Tuesday the shares had stabilised at €0.33, still 7.15% below the 52-week high of €0.36 reached in late May. Year-to-date gains remain substantial at 72.67%, but the sudden retreat underscores how heavily the hydrogen specialist’s valuation rests on market mood rather than tangible order flow.

The last mandatory disclosure came on 6 May – the launch of a new pressurised alkaline platform. That followed a 24 April announcement and a $7 million PEM equipment order on 23 April. With no catalyst for Monday’s rout, the selloff looks like a pure sentiment and positioning event, exacerbated by the stock having edged towards the upper end of its recent trading range. The current level now sits further below that ceiling.

Orders keep bleeding despite technology progress

The market’s sensitivity to any hint of weakness is rooted in the first-quarter numbers. Nel reported revenue from customer contracts of 148 million Norwegian kroner, down 5% from 155 million a year earlier. EBITDA came in at minus 100 million kroner, an improvement on the minus 115 million loss of the prior-year period, but the bottom line still showed a net loss of 144 million kroner.

More troubling is the order book. New orders totalled just 85 million kroner in the quarter, a collapse of 73% versus the prior year, while the order backlog shrank 24% to 1.113 billion kroner. The split between technologies tells two stories: the alkaline segment lifted quarterly sales by 6% to 75 million kroner, but the PEM division saw revenue drop 14% to 74 million kroner.

Cash pile buys time for new platform

The main counterweight to the weak order traction is Nel’s balance sheet. At the end of the quarter the company held around 1.443 billion kroner in cash, giving it breathing room to commercialise its new pressurised alkaline electrolyser system.

That platform, unveiled on 6 May after eight years of development, targets large-scale green hydrogen projects. At Herøya, it will enable production capacity of up to 1 gigawatt per year, with a potential expansion path to 4 GW. Crucially, for a 25 MW turnkey plant Nel aims for total installed costs below $1,450 per kW, addressing one of the industry’s biggest hurdles – high upfront capital expenditure. The industrialisation phase is backed by a grant from the EU Innovation Fund of up to €135 million, covering as much as 60% of eligible costs.

Investor focus shifts to July report

Product milestones alone, however, have not been enough to lift the cloud of uncertainty. The market is weighing a stronger technology platform against a deteriorating order intake and a shrinking backlog. Without new contract announcements, the stock remains hostage to sentiment around deal quality and cash burn.

The next hard date on the calendar is the half-year report on 15 July. Until then, investors will be looking for concrete order wins, especially from the new alkaline platform, to justify the rally that has already doubled the stock from its March low of €0.18. For now, a well-stocked treasury provides time but not proof that the commercial breakthrough is imminent.